1/28/2010-Procter & Gamble (NYSE:PG) reported fiscal Q2 EPS of $1.49, topping consensus estimates of $1.43. Sales in the quarter rose 6% year-over-year to $21.0 billion,...
Both J&J and Genentech Boost 2008 Profit Outlooks; Johnson & Johnson 2Q US Sales Up 2%, Global Sales Up 16%; Genentech Best Biotech Performer Today,...